Institut de biologie moléculaire et cellulaire
- Company typePrivate
- Founded1974
- HeadquartersStrasbourg, France
- Headcount11–50
- GTM typeB2B
- OfferingServices
Institut de biologie moléculaire et cellulaire firmographics
Firmographics- Name
- Institut de biologie moléculaire et cellulaire
- Legal name
- Institut de Biologie Moléculaire et Cellulaire
- Website
- https://ibmc.cnrs.fr
- Company type
- Private
- Founded year
- 1974
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
Institut de biologie moléculaire et cellulaire industry classification
Industry- Product category
- Academic Research Services
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Biomedical Sciences & Medical Research Institutes (University-Based) (EDAHAGAI)
- akta.pro secondary industry
- Proteomics & Mass Spectrometry Services (HLAGANAB)
Keywords
Where Institut de biologie moléculaire et cellulaire is headquartered
LocationHeadquarters
- HQ city
- Strasbourg
- HQ country
- France
- HQ region
- Europe
Offices1 record
Markets served
Institut de biologie moléculaire et cellulaire business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Infrastructure
Revenue model
- Public research funding: Public research institute funded by CNRS, University of Strasbourg, and INSERM with platform services provided to academic and private scientific community
Go-to-market motion1 record
Distribution channels1 record
Marketing channels3 records
Institut de biologie moléculaire et cellulaire product offering
Product offeringCore offering
IBMC is a public research institute conducting fundamental and translational research in molecular and cellular biology. It hosts three research units (ARN, I2CT, M3i) and operates shared technical platforms (Mass Spectrometry, SPF Animal Facility, Insectarium) that support studies in RNA biology, infectious diseases, immunology, biophysics, and multifunctional nanomaterials for academic and industry partners.
Product overview
IBMC is a CNRS-affiliated research institute comprising three research units (ARN, I2CT, M3i) and several technical platforms. The institute conducts fundamental research at the interface of molecular and cellular biology, immunology, chemistry, and biophysics, particularly in infectious diseases and infection resistance. Research units use and develop cutting-edge technologies ranging from high-resolution structural biology to integrative in vivo physiology, including multifunctional nanomaterials for therapeutic purposes. Technical platforms (mass spectrometry, SPF animal facility, insectarium) are open to the academic and private scientific community.
Differentiator
Problem solved
Functional benefit
Products and services
- Mass Spectrometry Platform
- SPF Animal Facility
- Insectarium
- ARN Research Unit
- I2CT Research Unit
- M3i Research Unit
Companies that use Institut de biologie moléculaire et cellulaire
Customer profileSegments2 records
Ideal customer profiles2 records
Institut de biologie moléculaire et cellulaire technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Institut de biologie moléculaire et cellulaire partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered core and minor.
- CNRS (Centre National de la Recherche Scientifique)corePrimary supervisory institution. CNRS provides institutional support and framework for the research institute, hosting IBMC as one of its federative research units.
- Université de StrasbourgcoreAssociated university providing academic support and collaboration for the research institute.
- INSERMcoreAssociated research institute contributing to research and innovation in health sciences.
- Cegedim.CloudminorCloud hosting provider for website infrastructure. Address: 137 rue d'Aguesseau, 92100 Boulogne-Billancourt, France.
Scale indicators3 records
Recent moves5 records
Expansion highlights3 records
Institut de biologie moléculaire et cellulaire competitors and assessment
Company assessmentDirect peers
- Centre for Genomic Regulation (CRG): Barcelona-based institute covering gene regulation, cell biology, and systems biology. Comparable as a publicly funded European molecular biology research center with shared technology platforms.
- MRC Laboratory of Molecular Biology: Cambridge-based MRC institute focused on molecular biology, structural biology, and neurobiology. Directly comparable for IBMC's structural biology and RNA biology work (ARN unit).
- Institut Pasteur: France's flagship biomedical research institute, also focused on infectious diseases, immunology, and molecular biology. Most directly comparable national peer in mission structure (federative research units plus technology platforms) and public funding model.
- Weizmann Institute of Science: Israeli multidisciplinary research institution covering biology, chemistry, and biophysics with a strong infectious-disease and immunology research tradition. Comparable as a publicly funded, research-excellence-driven institute.
- Institute of Molecular Biology (IMB), Mainz: German molecular biology research institute on the Mainz campus covering epigenetics, DNA repair, and quantitative biology. Comparable as a mid-sized, publicly funded European molecular biology research institute.
- Francis Crick Institute: UK's largest biomedical research institute covering cancer, infection, and fundamental biology across multiple research units. Directly comparable as a multi-unit, publicly funded life-sciences research institute with shared technology platforms.
- Max Planck Institute for Molecular Biomedicine: German Max Planck institute covering molecular biomedicine, cell biology, and vascular biology. Comparable publicly funded research unit structure focused on molecular and cellular biology.
Broad incumbents
- Wellcome Sanger Institute: UK genomics institute with broader scope focused on large-scale genomics and pathogen genomics. Comparable publicly funded UK life-sciences research organization with shared platform model.
- European Molecular Biology Laboratory (EMBL): Intergovernmental research organization covering molecular biology across six sites with broader scope than IBMC. Comparable as a publicly funded European molecular biology research network with shared platforms.
- Broad Institute of MIT and Harvard: US biomedical and genomics research institute, far larger and broader in scope than IBMC. Comparable as a multi-unit biomedical research organization with shared platforms for the scientific community.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
Institut de biologie moléculaire et cellulaire social profiles
Digital presenceInstitut de biologie moléculaire et cellulaire financial estimates
Financial estimateRevenue estimate
Valuation estimate
Institut de biologie moléculaire et cellulaire leadership team
Management profileNumber of profiles
Profiles2 records
Institut de biologie moléculaire et cellulaire subsidiaries and ownership
Company hierarchySubsidiaries7 records
Institut de biologie moléculaire et cellulaire funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Institut de biologie moléculaire et cellulaire M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Institut de biologie moléculaire et cellulaire
What does Institut de biologie moléculaire et cellulaire do?
IBMC is a public research institute conducting fundamental and translational research in molecular and cellular biology. It hosts three research units (ARN, I2CT, M3i) and operates shared technical platforms (Mass Spectrometry, SPF Animal Facility, Insectarium) that support studies in RNA biology, infectious diseases, immunology, biophysics, and multifunctional nanomaterials for academic and industry partners.
Is Institut de biologie moléculaire et cellulaire a public or private company?
Institut de biologie moléculaire et cellulaire is a private company. It is classified as state government owned and is currently operating.
When was Institut de biologie moléculaire et cellulaire founded?
Institut de biologie moléculaire et cellulaire was founded in 1974. It employs 11 to 50 people.
Where is Institut de biologie moléculaire et cellulaire based?
Institut de biologie moléculaire et cellulaire is headquartered in Strasbourg, France, in the Europe region.
How does Institut de biologie moléculaire et cellulaire make money?
One revenue line is on record: public research funding.
Who are Institut de biologie moléculaire et cellulaire's main competitors?
Direct peers on record are Centre for Genomic Regulation (CRG), MRC Laboratory of Molecular Biology, Institut Pasteur, Weizmann Institute of Science, Institute of Molecular Biology (IMB), Mainz, Francis Crick Institute and Max Planck Institute for Molecular Biomedicine. Broad incumbents are Wellcome Sanger Institute, European Molecular Biology Laboratory (EMBL) and Broad Institute of MIT and Harvard.
Does Institut de biologie moléculaire et cellulaire have an API?
No public API is recorded for Institut de biologie moléculaire et cellulaire.
What industry is Institut de biologie moléculaire et cellulaire in?
Institut de biologie moléculaire et cellulaire's product category is Academic Research Services. Its primary akta.pro industry code is EDAHAGAI, Biomedical Sciences & Medical Research Institutes (University-Based), with a secondary code of HLAGANAB, Proteomics & Mass Spectrometry Services. Its NAICS code is 541714 and its SIC code is 8731.